A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir J Plank, M Bodenlenz, F Sinner, C Magnes, E Gorzer, W Regittnig, ... Diabetes care 28 (5), 1107-1112, 2005 | 397 | 2005 |
β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis F Kolbinger, C Loesche, MA Valentin, X Jiang, Y Cheng, P Jarvis, ... Journal of Allergy and Clinical Immunology 139 (3), 923-932. e8, 2017 | 218 | 2017 |
Closing the loop: the adicol experience R Hovorka, LJ Chassin, ME Wilinska, V Canonico, JA Akwi, MO Federici, ... Diabetes technology & therapeutics 6 (3), 307-318, 2004 | 194 | 2004 |
Open flow microperfusion as a dermal pharmacokinetic approach to evaluate topical bioequivalence M Bodenlenz, KI Tiffner, R Raml, T Augustin, C Dragatin, T Birngruber, ... Clinical pharmacokinetics 56, 91-98, 2017 | 103 | 2017 |
Duration of action, pharmacodynamic profile and between-subject variability of insulin detemir in subjects with type 1 diabetes TR Pieber, J Plank, E Goerzer, R Sommer, A Wutte, F Sinner, ... Diabetes 51, A53-A53, 2002 | 79 | 2002 |
On‐line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with type 1 diabetes HC Schaller, L Schaupp, M Bodenlenz, ME Wilinska, LJ Chassin, P Wach, ... Diabetic medicine 23 (1), 90-93, 2006 | 66 | 2006 |
Comparison of Open-Flow Microperfusion and Microdialysis Methodologies When Sampling Topically Applied Fentanyl and Benzoic Acid in Human Dermis Ex Vivo R Holmgaard, E Benfeldt, JB Nielsen, C Gatschelhofer, JA Sorensen, ... Pharmaceutical research 29, 1808-1820, 2012 | 59 | 2012 |
Measurement of interstitial insulin in human adipose and muscle tissue under moderate hyperinsulinemia by means of direct interstitial access M Bodenlenz, LA Schaupp, T Druml, R Sommer, A Wutte, HC Schaller, ... American Journal of Physiology-Endocrinology and Metabolism 289 (2), E296-E300, 2005 | 59 | 2005 |
Subcutaneous adipose tissue exerts proinflammatory cytokines after minimal trauma in humans C Pachler, D Ikeoka, J Plank, H Weinhandl, M Suppan, JK Mader, ... American Journal of Physiology-Endocrinology and Metabolism 293 (3), E690-E696, 2007 | 56 | 2007 |
Clinical applicability of dOFM devices for dermal sampling M Bodenlenz, B Aigner, C Dragatin, L Liebenberger, S Zahiragic, ... Skin Research and Technology 19 (4), 474-483, 2013 | 52 | 2013 |
Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion. C Dragatin, F Polus, M Bodenlenz, C Calonder, B Aigner, KI Tiffner, ... Experimental dermatology 25 (2), 2016 | 51 | 2016 |
Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling M Bodenlenz, C Höfferer, C Magnes, R Schaller-Ammann, L Schaupp, ... European journal of pharmaceutics and biopharmaceutics 81 (3), 635-641, 2012 | 50 | 2012 |
Bedside monitoring of subcutaneous interstitial glucose in healthy individuals using microdialysis and infrared spectrometry. HM Heise, U Damm, M Bodenlenz, VR Kondepati, G Köhler, M Ellmerer Journal of Biomedical Optics 12 (2), 024004-024004, 2007 | 45 | 2007 |
Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus A Wutte, J Plank, M Bodenlenz, C Magnes, W Regittnig, F Sinner, B Rønn, ... Experimental and clinical endocrinology & diabetes 115 (07), 461-467, 2007 | 43 | 2007 |
Interstitial glucose kinetics in subjects with type 1 diabetes under physiologic conditions ME Wilinska, M Bodenlenz, LJ Chassin, HC Schaller, LA Schaupp, ... Metabolism 53 (11), 1484-1491, 2004 | 39 | 2004 |
Rapid online-SPE-MS/MS method for ketoprofen determination in dermal interstitial fluid samples from rats obtained by microdialysis or open-flow microperfusion KE Pickl, C Magnes, M Bodenlenz, TR Pieber, FM Sinner Journal of Chromatography B 850 (1-2), 432-439, 2007 | 27 | 2007 |
Open flow microperfusion: An alternative method to microdialysis? T Pieber, T Birngruber, M Bodenlenz, C Höfferer, S Mautner, K Tiffner, ... Microdialysis in Drug Development, 283-302, 2013 | 25 | 2013 |
Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open‐flow microperfusion M Bodenlenz, M Ellmerer, L Schaupp, LV Jacobsen, J Plank, GA Brunner, ... Diabetes, Obesity and Metabolism 17 (12), 1166-1172, 2015 | 22 | 2015 |
Kinetics of Clobetasol-17-propionate in psoriatic Lesional and non-Lesional skin assessed by dermal open flow microperfusion with time and space resolution M Bodenlenz, C Dragatin, L Liebenberger, B Tschapeller, ... Pharmaceutical Research 33, 2229-2238, 2016 | 20 | 2016 |
Variability of skin pharmacokinetic data: insights from a topical bioequivalence study using dermal open flow microperfusion M Bodenlenz, T Augustin, T Birngruber, KI Tiffner, B Boulgaropoulos, ... Pharmaceutical Research 37, 1-11, 2020 | 18 | 2020 |